NO20060268L - Enalapril-nitroksyderivater og beslektede forbindelser som ACE-inhibitorer for behandling av kardiovaskulaere sykdommer - Google Patents

Enalapril-nitroksyderivater og beslektede forbindelser som ACE-inhibitorer for behandling av kardiovaskulaere sykdommer

Info

Publication number
NO20060268L
NO20060268L NO20060268A NO20060268A NO20060268L NO 20060268 L NO20060268 L NO 20060268L NO 20060268 A NO20060268 A NO 20060268A NO 20060268 A NO20060268 A NO 20060268A NO 20060268 L NO20060268 L NO 20060268L
Authority
NO
Norway
Prior art keywords
enalapril
treatment
ace inhibitors
cardiovascular diseases
related compounds
Prior art date
Application number
NO20060268A
Other languages
English (en)
Inventor
Piero Del Soldato
Ennio Ongini
Nicoletta Almirante
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of NO20060268L publication Critical patent/NO20060268L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Forbindelser med formel (I): A-(Xi- 0N02)s, hvor A er en kjent ACE-inhibitor som Enalapril, og Xi er et (C1-C6) alkylen. Den fullstendige definisjon av A og Xi er gitt i krav 1. Forbindelsene kan anvendes som ACE-inhibitorer for behandling av kardio-vaskulære og renale sykdommer og inflammasjonsprosesser. Forbindelsen med formel (I) har forbedret farmakologisk aktivitet sammenlignet med den strukturmessig nærmest beslektede kjente forbindelse.
NO20060268A 2003-06-19 2006-01-18 Enalapril-nitroksyderivater og beslektede forbindelser som ACE-inhibitorer for behandling av kardiovaskulaere sykdommer NO20060268L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03101796 2003-06-19
PCT/EP2004/051089 WO2004110432A1 (en) 2003-06-19 2004-06-11 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases

Publications (1)

Publication Number Publication Date
NO20060268L true NO20060268L (no) 2006-03-15

Family

ID=33547744

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060268A NO20060268L (no) 2003-06-19 2006-01-18 Enalapril-nitroksyderivater og beslektede forbindelser som ACE-inhibitorer for behandling av kardiovaskulaere sykdommer

Country Status (18)

Country Link
US (1) US7217733B2 (no)
EP (1) EP1635816B1 (no)
KR (1) KR20060021900A (no)
CN (1) CN1809345A (no)
AR (1) AR044839A1 (no)
AT (1) ATE424199T1 (no)
AU (1) AU2004246821A1 (no)
BR (1) BRPI0411430A (no)
CA (1) CA2529478A1 (no)
DE (1) DE602004019779D1 (no)
ES (1) ES2322263T3 (no)
IL (1) IL172018A0 (no)
MX (1) MXPA05013771A (no)
NO (1) NO20060268L (no)
PL (1) PL379197A1 (no)
RU (1) RU2006100827A (no)
WO (1) WO2004110432A1 (no)
ZA (1) ZA200600526B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004266705A1 (en) * 2003-08-20 2005-03-03 Nitromed, Inc. Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
MX2007002210A (es) 2004-08-26 2007-05-07 Nicholas Piramal India Ltd Profarmacos que contienen enlazantes bioescindibles novedosos.
WO2007045551A2 (en) * 2005-10-18 2007-04-26 Nicox S.A. Renin inhibitors nitroderivatives
WO2008095841A2 (en) 2007-02-05 2008-08-14 Nicox S.A. Nitric oxide donor compounds
CA2709071C (en) 2007-12-14 2016-11-15 Labogroup S.A.S. Delivering aerosolizable food products
AR073259A1 (es) * 2008-07-29 2010-10-28 Merck & Co Inc Derivados de furosemida utiles como diureticos
WO2011160974A2 (en) 2010-06-21 2011-12-29 Nicox S.A. Statin derivatives
JO3350B1 (ar) 2011-03-07 2019-03-13 Merck Sharp & Dohme مشتقات حلقية غير متجانسة محتوية على مجموعات أمينو أولية ومركبات داي أزينيومديولات

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4574079A (en) * 1983-05-27 1986-03-04 Gavras Haralambos P Radiolabeled angiotensin converting enzyme inhibitors for radiolabeling mammalian organ sites
IT1276071B1 (it) 1995-10-31 1997-10-24 Nicox Ltd Compositi ad attivita' anti-infiammatoria
IT1295694B1 (it) * 1996-11-14 1999-05-27 Nicox Sa Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
IT1311924B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1311923B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1314184B1 (it) 1999-08-12 2002-12-06 Nicox Sa Composizioni farmaceutiche per la terapia di condizioni di stressossidativo

Also Published As

Publication number Publication date
EP1635816B1 (en) 2009-03-04
KR20060021900A (ko) 2006-03-08
IL172018A0 (en) 2009-02-11
EP1635816A1 (en) 2006-03-22
US7217733B2 (en) 2007-05-15
PL379197A1 (pl) 2006-07-24
ZA200600526B (en) 2007-01-31
MXPA05013771A (es) 2006-03-08
BRPI0411430A (pt) 2006-07-25
ES2322263T3 (es) 2009-06-18
AR044839A1 (es) 2005-10-05
RU2006100827A (ru) 2007-07-27
AU2004246821A1 (en) 2004-12-23
DE602004019779D1 (de) 2009-04-16
US20050004100A1 (en) 2005-01-06
CA2529478A1 (en) 2004-12-23
WO2004110432A1 (en) 2004-12-23
ATE424199T1 (de) 2009-03-15
CN1809345A (zh) 2006-07-26

Similar Documents

Publication Publication Date Title
NO20060268L (no) Enalapril-nitroksyderivater og beslektede forbindelser som ACE-inhibitorer for behandling av kardiovaskulaere sykdommer
NO20044731L (no) Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
NO20051600L (no) 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer
DE602005016297D1 (de) Antithrombotische diamide
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
NO20071617L (no) Indozolonderivater som 11B-HSD1-inhibitorer
NO20052487L (no) 1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater.
MA26956A1 (fr) Pyrimidine-2,4,6,triones inhibitrices de metalloproteinases.
NO20053627L (no) Malonamidderivater som gamma-sekretase inhibitorer
PL361404A1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
TW200510311A (en) CCr8 inhibitors
ATE411288T1 (de) Aryl-, aryloxy- und alkyloxysubstituierte 1h- indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
EA200701504A1 (ru) Индолы, пригодные для лечения воспалений
NO20006157L (no) Celleadhesjons-inhiberende anti-inflammatoriske forbindelser
NO20084872L (no) 2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig
HK1087702A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
MXPA05013536A (es) Derivados de etinilprolina.
NO20073170L (no) Kaspaseinhibitorer og anvendelse derav
ATE308540T1 (de) Antithrombosemittel
NO20053726L (no) Forbindelser med prolyloligopeptidase-hemmende aktivitet
ATE372982T1 (de) 2-(3-sulfonylamino-2-oxopyrrolidin-1- yl)propanamide als factor xa inhibitoren
DE60232802D1 (de) Neues mandelsäurederivat und seine verwendung als thrombininhibitor
TW200716620A (en) Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitors
WO2024044744A3 (en) Peroxiredoxin 3 inhibitors and methods of use for treating cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application